507.        Asia Pacific Cohort Studies Collaboration. “Blood Glucose and Risk of Cardiovascular Disease in the Asia Pacific Region.” Diabetes CareVolume 27, Number 12, Pages 2836-2842. 2004.http://care.diabetesjournals.org/cgi/content/full/27/12/2836

508.        Meigs JB, et al. “Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk: The Framingham Offspring Study.” Diabetes Care, a journal of the American Diabetes Association, Volume 25, Number 10, Pages 1845-1850, 2002.http://care.diabetesjournals.org/cgi/content/abstract/25/10/1845

509.        Stratton IM, et al. “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.” British Medical Journal, Volume 321, Number 7258, Pages 405–412. August 12, 2000. http://www.bmj.com/cgi/content/abstract/321/7258/405

510.        Romney JS and Lewanczuk RZ. “Vascular Compliance Is Reduced in the Early Stages of Type 1 Diabetes.” Diabetes Care, Volume 24, Issue 12, Pages 2102-2105. December 2001.http://care.diabetesjournals.org/cgi/content/abstract/24/12/2102

511.        Manaviat MR, Afkhami M and Shoja, MR. “Retinopathy and microalbuminuria in type II diabetic patients.” Ophthalmology of BMC, Volume 4, Number 9. 2004.http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=459228

512.        Brand-Miller JC. “Glycemic index in relation to coronary disease.” Asian Pacific Journal of Clinical Nutrition, Volume 13, Supplement S3.  2004.

513.        Selvin E, et al” Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes.” Archives of Internal Medicine, Volume 165, Number 16, Pages1910-1916. September 12, 2005. http://archinte.ama-assn.org/cgi/content/abstract/165/16/1910?etoc

514.        Das UN. “Is insulin an endogenous cardioprotector” Critical Care, Volume 6, Number 5, Pages 389–393. July 31, 2002.http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=137317

515.        Wong, VW, et al. “C-Reactive Protein Levels Following Acute Myocardial Infarction: Effect of insulin infusion and tight glycemic control.” Diabetic Care, Volume 27, Number 12, Pages 2971-2973, 2004.http://care.diabetesjournals.org/cgi/content/full/27/12/2971

516.        Bursi F, et al. “ C-Reactive Protein and Heart Failure After Myocaridal Infarction in the Community.” The American Journal of Medicine, Volume 120, Number 7; Pages 616-622. July 2007.http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TDC-4NKB1YW-2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=dc96e15b7451b7b9d8162af1aa59aab6

517.        Aronson D and Rayfield, EJ. “How hyperglycemia promotes atherosclerosis: molecular mechanisms.” Cardiovascular Diabetology, Volume 1, Number 1. 2002. http://www.cardiab.com/content/1/1/1

518.        News Watch; Internal Medicine World Report. January 2007.http://www.imwr.com/print.php?s=IMWR/2007/01&p=7

519.        Sprinivasan S, et al. “Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.” Diabetologia. Volume 47, Number 10, October 2004.http://www.springerlink.com/content/j0ndjh5d1rphkpmh

520.        Halton TL, et al. “Low-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women.” New England Journal of Medicine. Volume 355, Number 19, Pages 1991-2002. November 9, 2006.http://content.nejm.org/cgi/content/full/355/19/1991

521.        Srinivasan S, et al. “Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.” Diabetologia. Volume 47, Pages 727–1734. 2004.http://www.springerlink.com/content/j0ndjh5d1rphkpmh

522.        Dandona P. et al. “Insulin infusion in acute illness.” Journal of  Clinical Investigation. Volume 115, Number 8, Pages 2069–2072. August 1, 2005.http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1180564&blobtype=pdf

523.        Khaw K-T, et al. “Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk).” British Medical Journal.  Volume 322, Number 7277, Page 15-20. January 6, 2001.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26599

524.        Veiraiah A. “Hyperglycemia, lipoprotein glycation, and vascular disease.”Angiology. 2005 Jul-Aug Volume 56, Number 4, Pages 431-8. July-August 2005. http://www.ncbi.nlm.nih.gov/entrez/eutils/escan.fcgi?db=PubMed&uid=16079928&dopt=Citation&field=Title&DateField=MeshDate

525.        Lamharzi N, et al. “Hyperlipidemia in Concert With Hyperglycemia Stimulates the Proliferation of Macrophages in Atherosclerotic Lesions. Potential Role of Glucose-Oxidized LDL.” Diabetes.  Volume 53, Pages 3217-3225. 2004.http://diabetes.diabetesjournals.org/cgi/reprint/53/12/3217

526.        Zhang J, et al. “Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells.”  Arteriosclerosis, Thrombosis, and Vascular Biology. Volume18, Number 7, Pages 140-1148. 1998. http://atvb.ahajournals.org/cgi/reprint/18/7/1140

527.        Wauther JL and Guillausseau PJ. “ADVANCED GLYCATION END PRODUCTS, THEIR RECEPTORS AND DIABETIC ANGIOPATHY.”Diabetes and Metabolism. (Paris) Volume 27, Pages 535-542. 2001.http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=11694852&cmd=showdetailview&indexed=google

528.        Lachin JM, et al. “The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial.” Diabetes.. Volume 56, Number 7, Pages 1161-1772. 2007. http://www.medscape.com/viewarticle/560882_print

529.        Verma S, et al. “Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone.” Journal of Molecular and Cellular Cardiology. Volume 35, Issue 4, Pages 417-419. April 2003.http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12689821&dopt=Abstract

530.        Pauletto P and Rattazzi M. “Inflammation and hypertension: the search for a link.” Nephrology Dialysis Transplantation. Volume 21, Number 4, Pages 850-853. 2006. http://ndt.oxfordjournals.org/cgi/reprint/21/4/850.pdf

531.        Engström G, et al. “Inflammation-Sensitive Plasma Proteins, Diabetes, and Mortality and Incidence of Myocardial Infarction and Stroke.” Diabetes. Volume 52, Number 2, Pages 442-447. 2003.http://diabetes.diabetesjournals.org/cgi/reprint/52/2/442

532.        Tuttle HA, et al. “Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease.” Cardiovascular Diabetology. 2003; Volume 2, Number 12. October 4, 2003.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=270088

533.        Capes SE, et al. “Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.” The Lancet. Volume 355, Issue 9206, Pages 773-778. March 4, 2000. http://www.ncbi.nlm.nih.gov/pubmed/10711923

534.        Hayden MR and Tyagi SC. “Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.” Cardiovascular Diabetology. Volume 1, Number 3. 2002. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=140143

535.        Hayden MR and Tyagi SC. “Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.” Cardiovascular Diabetology. Volume 2, Number 2. 2003. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=151667

536.        Hayden MR, et al. “The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded.” Cardiovascular Diabetology. Volume 4, Number 9. 2005. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1175853

537.        Pepys MB and Berger A. “Editorials: The renaissance of C- reactive protein.” British Medical Journal. Volume 322, Number 7277, Pages 4-5. January 6, 2001. http://bmj.bmjjournals.com/cgi/content/full/322/7277/4

538.        Savoia C and Schffrin EL “Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions..” Clinical Science. (London) Volume 112, Number 7, Pages 375-84. June 2007.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&dopt=Citation&list_uids=17324119

539.        Videm V, et al. “Multiple inflammatory markers in patients with significant coronary artery disease.” International Journal of  Cardiology. Volume118, Number 1, Pages 81-7. May 16, 2007.http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T16-4KRY8KJ-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=1cb1fb44057ef170a890c25f0d21c352

540.        Orio F, et al. “The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome.” Journal of Clinical Endocrinology & Metabolism. Volume 90, Number 1, Pages 2–5. 2005.http://jcem.endojournals.org/cgi/reprint/90/1/2

541.        Asia Pacific Cohort Studies Collaboration. “Blood Glucose and Risk of Cardiovascular Disease in the Asia Pacific Region.” Diabetes Care. Volume 27, Pages 2836-2842. 2004.http://care.diabetesjournals.org/cgi/content/full/27/12/2836

542.        Dickinson S and Brand-Miller J. “Glycemic index, postprandial glycemia and cardiovascular disease.” Current Opinion in Lipidology. Volume 16, Pages 69–75. 2005. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pubmed&dopt=AbstractPlus&list_uids=15650566

543.        Tushuizen ME, et al. “Elevated Endothelial Microparticles Following Consecutive Meals Are Associated With Vascular Endothelial Dysfunction in Type 2 Diabetes.” Diabetes Care. Volume 30, Pages 728-730, 2007, http://care.diabetesjournals.org/cgi/reprint/30/3/728

544.        Lorenzi M, et al. “High glucose induces DNA damage in cultured human endothelial cells.” Journal of Clinical Investigation, Volume 77, Number 1, Pages 322–325. January 1986.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=423344

545.        Du XL, et al. “Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.” Journal of Clinical Investigation. Volume 108, Number 9, Pages 1341–1348. November 1, 2001. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=209429

546.        Anderson RA, et al. “The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes.” Atherosclerosis. Volume 154, Number 2, Pages 475-83. February 1, 2001.http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11166782&dopt=AbstractPlus

547.        Mozaffarian D, et al. “Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women.” American Journal of Clinical Nutrition, Volume 80, Number5, Pages 1175-84. November 2004. http://www.ajcn.org/cgi/content/full/80/5/1175

548.        Carnethon MR, et al. “The Association Among Autonomic Nervous System Function, Incident Diabetes, and Intervention Arm in the Diabetes Prevention Program.” DIABETES CARE. Volume 29, Number 4, Pages 914–919. April 2006.http://care.diabetesjournals.org/cgi/content/full/29/4/914

549.        Pop-Busui R, et al. “Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction.” Journal of the American College of Cardiology, Volume 44, Number 12, Pages 2368-2374. 2004.http://content.onlinejacc.org/cgi/content/figsonly/44/12/2368

550.        Eckel RH, et al. “Preventing Cardiovascular Disease and Diabetes. A call to action from the American Diabetes Association and the American Heart Association.” Diabetes Care. Volume 29, Number 7, Pages1697-1699. 2006. http://care.diabetesjournals.org/cgi/content/full/29/7/1697 orCirculation. Volume113, Pages 2943-2946. 2006.http://circ.ahajournals.org/cgi/reprint/113/25/2943

551.        McLaughlin T, et al. “Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults.” American Journal of Clinical Nutrition, Volume 84, Number 4, Pages 813-821. October 2006.http://www.ajcn.org/cgi/reprint/84/4/813

552.        Hays JH, et al. “Effect of a High Saturated Fat and No-Starch Diet on Serum Lipid Subfractions in Patients With Documented Atherosclerotic Cardiovascular Disease.” Mayo Clinic Proceedings. Volume 78, Pages 1331-1336. 2003. http://www.mayoclinicproceedings.com/inside.asp?a=1&ref=7811a1

553.        Abdul-Rahman M, et al. “A High-Fat Diet in Obese Patients Induces Weight Loss, Leads to Improved Insulin Resistance, and Lowers Systolic Blood Pressure Despite Marked Increase in Dietary Sodium Intake.” Endocrine Practice. Abstract-Obesity #201. Volume12, Supplement 2, Page 50. 2006. http://www.aace.com/meetings/ams/2006/pdfs/2006AM-Abstracts.pdf

554.        Sauvaget C, et al. “Animal Protein, Animal Fat, and Cholesterol Intakes and Risk of Cerebral Infarction Mortality in the Adult Health Study.”Stroke. Volume 35, Pages 1531-1537. 2004.http://stroke.ahajournals.org/cgi/content/full/35/7/1531

555.        Khaw KT, et al. “Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk).” British Medical Journal. Volume 322, Number 7277, Pages 15. January 6, 2001.http://www.bmj.com/cgi/reprint/322/7277/15

556.        Barrett-Connor E and Wingard DL. “Editorials: ‘Normal’ Blood Glucose and Coronary Risk.” British Medical Journal. Volume 322, Number 7277, Pages 5-6. January 6, 2001. British Medical Journal. Volume 322, Number 7277, Pages 15. January 6, 2001.http://www.bmj.com/cgi/reprint/322/7277/5

557.        Tamarat R, et al. “Blockade of advanced glycation end-product formation restores ischemia- induced angiogenesis in diabetic mice.” Proceedings of the National Academy of Science of the United States of America. Volume 100, Number 14, Pages 8555–8560. July 8, 2003.http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=166267

558.        Perticone F, et al. “Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension.” Circulation.  Published online Aug 2, 2004.http://www.circ.ahajournals.org/cgi/reprint/01.CIR.0000138745.21879.27v1

559.        de Roos NM, et al. “Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation.”European Journal of Clinical Nutrition. Volume 56, Number 7, Pages 674–679. 2002. http://www.nature.com/ejcn/journal/v56/n7/pdf/1601377a.pdf

560.        Raitakari OT, et al. “Enhanced peripheral vasodilation in humans after a fatty meal.” Journal of American College of Cardiology. Volume 36, Number 2, Pages 417-22. August 2000.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10933351&itool=iconabstr

561.        McClain DA, et al. “Glucose and Glucosamine Regulate Growth Factor Gene Expression in Vascular Smooth Muscle Cells.”  Proceedings of the National Academy of Science of the United States of America. Volume 89, Number 14, Pages 8150-8154. September 1992.http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=49874

562.        Morigi M, et al. “Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.” Journal of Clinical Investigation. Volume 101, Number 9, Pages 1905–1915. May 1, 1998.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstract&artid=508777

563.        Igarashi J and Michel T. “More sweetness than light? A search for the causes of diabetic vasculopathy.” Journal of Clinical Investigation, Volume 108, Number 10, Pages 1425–1427. November 15, 2001.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=209431

564.        Podrez EA, et al. “Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.” Journal of Clinical Investigation, Volume 103, Number 11, Pages 1547-1560. June 1, 1999.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=408366

565.        Hayden MR and Tyagi SC. “Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.” Cardiovascular Diabetology. Volume 3, Number1. 2004. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=356925

566.        ROMNEY JS and LEWANCZUK RZ. “Vascular Compliance Is Reduced in the Early Stages of Type 1 Diabetes.” Diabetes Care. Volume 24, Number 12, Pages 2102–2106, 2001.http://care.diabetesjournals.org/cgi/reprint/24/12/2102.pdf

567.        Caballero AE, et al. “Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.” Diabetes. Volume 48, Issue 9, Pages  1856-1862. 1999.http://diabetes.diabetesjournals.org/cgi/reprint/48/9/1856

568.        Nosadini R. et al. “Role of hyperglycemia and insulin resistance in determining sodium retention in non-insulin-dependent diabetes.” Kidney International. Volume 44, Number 1, Pages 139-46. July 1993.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8355455&itool=iconabstr&query_hl=5

569.        Appiani AC, et al. “Sodium excretion and hyperfiltration during glucose infusion in man.” American Journal of Nephrology. Volume 10, Number 2, Pages103-8. 1990. http://grande.nal.usda.gov/ibids/index.php?mode2=detail&origin=ibids_references&therow=309627

570.        Modan M, et al. “Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.” Journal of Clinical Investigation, Volume 75, Number 3, Pages 809–817. March 1985.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=423608

571.        McCarty MF. “Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension.” Medical Hypotheses. Volume 42, Number 4, Pages 226-36. April 1994. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8072428&itool=iconabstr

572.        Baron AD, et al. “Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men.” Journal of Clinical Investigation, Volume 93, Number 6, Pages 2453-2462. June 1994. http://www.pubmedcentral.gov/articlerender.fcgi?artid=294454

573.        Sampson M, et al. “Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.” Cardiovascular Diabetology. Volume 3, Number 7. 2004. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=441397

574.        Hayden MR and Tyagi SC. “Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.” Nutrition &  Metabolism (London). Volume 1, Number 10. 2004.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=529248

575.        Ceriello A. “ Editorials: Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction.” Diabetes Care. Volume 27, Number 12, Pages 3017-3018. 2004.http://care.diabetesjournals.org/cgi/reprint/27/12/3017

576.        The Diabetes Prevention Program Research Group. “Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance." Diabetes. Volume 54, Number 5, Pages 1566–1572. May 2005.http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1314967

577.        Steinberg HO, et al. “Obesity/Insulin Resistance Is Associated with Endothelial Dysfunction.” Journal of Clinical Investigation, Volume 97, Number 11, Pages 2601-2610. June 1996,http://www.jci.org/97/11/2601/pdf

578.        Kanagala R, et al. “Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation.” Circulation. Volume 107, Number 20, Pages 2589-2594. 2003. http://circ.ahajournals.org/cgi/content/full/107/20/2589

579.        Levitan EB, et al. “Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men.” American Journal of Clinical Nutrition, Volume 85, Number 6,Number 6, Pages 1521-1526, June 2007. http://www.ajcn.org/cgi/content/abstract/85/6/1521

580.        Cordain L, et al. “The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic.” European Journal of Clinical Nutrition. Volume 56, Supplement 1, Pages S42–S52. 2002. http://www.nature.com/ejcn/journal/v56/n1s/pdf/1601353a.pdf

581.        Eberly LE, et al. “Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease.” Archives of Internal Medicine. Volume 163, Number 9, Pages 1077-1083. 2003.http://archinte.ama-assn.org/cgi/reprint/163/9/1077

582.        Danesh J, et al. “Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease.” Journal of American Medical Association.  Volume 279, Number 18, Pages 1477-1482. 1998.http://jama.ama-assn.org/cgi/reprint/279/18/1477

583.        Shankar A, et al. “The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study.” Atherosclerosis. Volume 192, Issue 1, Pages 177-183. May 2007. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T12-4K2SKCV-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7272e5e1be7804ff9ea267cb48a97fca

584.        Elkind MS, et al. “Elevated White Blood Cell Count and Carotid Plaque Thickness: The Northern Manhattan Stroke Study.” Stroke. Volume 32,Number 4, Pages 842-849. 2001.http://stroke.ahajournals.org/cgi/content/full/32/4/842

585.        Margolis KL, et al. “Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women. The Women’s Health Initiative Observational Study.” Archives of Internal Medicine. Volume 165, Number 5, Pages 500-508. 2005. http://archinte.ama-assn.org/cgi/reprint/165/5/500

586.        Braga-Basaria M, et al. “Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy.” Journal of Clinical Oncology. Volume 24, Number 24, Pages 3979-3983. August 20, 2006.http://jco.ascopubs.org/cgi/reprint/24/24/3979

587.        Webster KA. “Stress hyperglycemia and enhanced sensitivity to myocardial infarction.” Current Hypertension Reports. Volume 10, Number 1, Pages 78-84. February 2008.http://www.springerlink.com/content/q63u775j0863756u

588.        Madjid M, et al. “Leukocyte count and coronary heart disease. Implications for risk assessment." Journal of the American College of Cardiology. Volume 44, Number 10, Pages 1945–56.  2004.http://content.onlinejacc.org/cgi/reprint/44/10/1945?ck=nck

589.        Sies H, et al. “Nutritional, Dietary and Postprandial Oxidative Stress.”Journal of Nutrition. Volume 135, Number 5, Pages 969-972, May 2005.http://jn.nutrition.org/cgi/reprint/135/5/969          

590.        Zhang C, et al. “Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality.” Circulation. Volume 117, Issue 13, Pages 1658-1667. April 1, 2008.http://circ.ahajournals.org/cgi/content/abstract/117/13/1658